Literature DB >> 10930436

Sickle cell anemia as an inflammatory disease.

O S Platt1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10930436      PMCID： PMC314335          DOI： 10.1172/JCI10726

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies.

Authors:  R P Hebbel
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

3.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

4.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

5.  Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease.

Authors:  M S West; D Wethers; J Smith; M Steinberg
Journal:  J Clin Epidemiol       Date:  1992-08       Impact factor: 6.437

6.  Genetic influences on F cells and other hematologic variables: a twin heritability study.

Authors:  C Garner; T Tatu; J E Reittie; T Littlewood; J Darley; S Cervino; M Farrall; P Kelly; T D Spector; S L Thein
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

7.  Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease.

Authors:  T R Kinney; L A Sleeper; W C Wang; R A Zimmerman; C H Pegelow; K Ohene-Frempong; D L Wethers; J A Bello; E P Vichinsky; F G Moser; D M Gallagher; M R DeBaun; O S Platt; S T Miller
Journal:  Pediatrics       Date:  1999-03       Impact factor: 7.124

8.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

9.  The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.

Authors:  O Castro; D J Brambilla; B Thorington; C A Reindorf; R B Scott; P Gillette; J C Vera; P S Levy
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113
  9 in total
  91 in total

1.  Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.

Authors:  Weili Bao; Hui Zhong; Xiaojuan Li; Margaret T Lee; Joseph Schwartz; Sujit Sheth; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2011-09-26       Impact factor: 10.047

2.  Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

Authors:  Dhananjay K Kaul; Xiao-du Liu; Hee-Yoon Chang; Ronald L Nagel; Mary E Fabry
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

3.  High levels of neopterin and interleukin-3 in sickle cell disease patients.

Authors:  L Rodrigues; F F Costa; S T O Saad; H Z W Grotto
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

5.  Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease.

Authors:  Shushan Zhao; Morayo G Adebiyi; Yujin Zhang; Jacob P Couturier; Xuegong Fan; Hongqi Zhang; Rodney E Kellems; Dorothy E Lewis; Yang Xia
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

6.  Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (c-Jun N-Terminal Kinase).

Authors:  Hannah Song; Philip M Keegan; Suhaas Anbazhakan; Christian P Rivera; Yundi Feng; Victor O Omojola; Alexus A Clark; Shuangyi Cai; Jada Selma; Rudolph L Gleason; Edward A Botchwey; Yunlong Huo; Wenchang Tan; Manu O Platt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-12       Impact factor: 8.311

7.  Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

8.  Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.

Authors:  Selma Unal; Ozlem Ozdemir; Ahmet Ata Ozcimen; Yesim Oztas
Journal:  Int J Hematol       Date:  2014-12-06       Impact factor: 2.490

9.  Rapid assembly of oligosaccharides: a highly convergent strategy for the assembly of a glycosylated amino acid derived from PSGL-1.

Authors:  Yusuf Vohra; Therese Buskas; Geert-Jan Boons
Journal:  J Org Chem       Date:  2009-08-21       Impact factor: 4.354

Review 10.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.